Every Form 4 that iRhythm Holdings, Inc. (IRTC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow IRTC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IRTC filings page.
iRhythm Holdings, Inc. Chief Accounting Officer Marc Wade Rosenbaum reported two transactions in common stock. On February 24, 2026, he acquired 9,210 shares at $0.00 per share through a grant determined by the board’s Compensation & Human Capital Management Committee after performance conditions for previously granted performance RSUs were met. On February 25, 2026, he sold 4,797 shares at an average price of $135.4189 per share to cover tax withholding and remittance obligations related to the vesting of those performance RSUs. Following these transactions, he directly owned 15,014 shares of iRhythm common stock.
iRhythm Holdings executive Chad Patterson reported a mix of stock transactions. On February 24, 2026, he acquired 17,318 shares of common stock at $0.00 per share through the vesting of performance RSUs, after the board’s Compensation & Human Capital Management Committee determined performance conditions for RSUs granted on February 27, 2023 were met. On February 25, 2026, he sold 8,967 shares of common stock at an average price of $135.4189 per share to cover tax withholding and remittance obligations related to that vesting. Following these transactions, he directly owned 51,738 shares of iRhythm common stock.
iRhythm Holdings, Inc. executive Patrick Michael Murphy, the company’s CBO and CLO, acquired 15,060 shares of common stock on a grant/award basis after performance conditions were met for previously granted performance RSUs. On the following day, he sold 7,805 shares in open-market transactions at an average price of $135.4189 per share to cover tax withholding and remittance obligations related to the vesting. After these transactions, he directly owned 60,536 shares of iRhythm common stock.
iRhythm Holdings President and CEO Quentin S. Blackford reported a performance-based stock vesting and related tax sale. On February 24, he acquired 46,687 shares of common stock at no cost through the vesting of performance RSUs granted on February 27, 2023, after the board committee determined the performance conditions were met.
On February 25, he sold 25,540 shares of common stock at an average price of $135.4189 per share solely to cover tax withholding and remittance obligations tied to that vesting. After these transactions, he directly owned 186,126 shares of iRhythm common stock.
iRhythm Holdings, Inc. Chief Accounting Officer Marc Wade Rosenbaum reported an open-market sale of 280 shares of common stock at an average price of $140.91 per share on February 24, 2026. After this sale, he directly holds 10,601 shares of iRhythm common stock.
The transaction was executed under a pre-arranged Rule 10b5-1 trading plan that he established on May 12, 2025 and modified on November 25, 2025, which is designed to allow systematic share sales according to preset instructions.
iRhythm Holdings, Inc. executive vice president of strategic business operations Mervin Smith reported an open-market sale of common stock. On February 24, 2026, he sold 732 shares at an average price of $140.91 per share.
After this transaction, Smith directly owned 15,106 shares of iRhythm common stock. The sale was executed under a pre-established Rule 10b5-1 trading plan that Smith adopted on November 19, 2025, indicating the trades were made according to a predetermined schedule.
iRhythm Holdings, Inc. director Abhijit Y. Talwalkar reported exercising employee stock options for 5,312 shares at $10.710 per share and receiving an equal number of common shares on February 23, 2026. He then sold 5,312 common shares in multiple open-market transactions at prices including $143.400, $145.317, $146.951, and $147.616 per share, leaving 20,299 shares of common stock held directly.
All transactions were carried out under a Rule 10b5-1 trading plan established on May 12, 2025. The exercised option was originally granted on May 23, 2016 for 21,248 shares, vested in thirty-six equal monthly installments, and has an expiration date of May 23, 2026; the plan covers options expiring in 2026 and 2027.
iRhythm Technologies (IRTC) reported an insider transaction by its President and CEO, who is also a Director. On 11/03/2025, the officer sold 14,059 shares of common stock at a price of $182.9367 per share.
The filing states the shares were sold to cover tax withholding and remittance obligations related to the vesting of Restricted Stock Units. Following the sale, the officer beneficially owns 164,979 shares, held directly.
iRhythm Technologies (IRTC) reported an insider transaction on Form 4. The company’s Chief Financial Officer sold 8,000 shares of common stock at $207.44 on 10/31/2025 pursuant to a Rule 10b5-1 trading plan established on November 14, 2024. Following the sale, the officer beneficially owns 26,470 shares directly and 100 shares indirectly through The Wilson Living Trust.